Compare TCBK & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBK | CDNA |
|---|---|---|
| Founded | 1975 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1995 | 2007 |
| Metric | TCBK | CDNA |
|---|---|---|
| Price | $55.48 | $47.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $54.60 | $28.00 |
| AVG Volume (30 Days) | 273.8K | ★ 1.1M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ 6.94 | N/A |
| EPS | 2.10 | ★ 2.13 |
| Revenue | ★ $53,445,000.00 | $48,324,000.00 |
| Revenue This Year | $12.03 | $16.01 |
| Revenue Next Year | $4.47 | $11.31 |
| P/E Ratio | $26.57 | ★ $21.84 |
| Revenue Growth | 4.12 | ★ 18.93 |
| 52 Week Low | $40.44 | $12.28 |
| 52 Week High | $61.71 | $49.76 |
| Indicator | TCBK | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | N/A |
| Support Level | $48.57 | N/A |
| Resistance Level | $59.01 | N/A |
| Average True Range (ATR) | 0.89 | 0.00 |
| MACD | -0.40 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income. Its banking and financial services are provided through full-service branches and commercial banking offices across California.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.